GB1173322A - Pharmaceutical Compositions containing Proscillaridin A - Google Patents
Pharmaceutical Compositions containing Proscillaridin AInfo
- Publication number
- GB1173322A GB1173322A GB2723569A GB2723569A GB1173322A GB 1173322 A GB1173322 A GB 1173322A GB 2723569 A GB2723569 A GB 2723569A GB 2723569 A GB2723569 A GB 2723569A GB 1173322 A GB1173322 A GB 1173322A
- Authority
- GB
- United Kingdom
- Prior art keywords
- theophylline
- proscillaridin
- compositions
- cardioactive
- dec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- MYEJFUXQJGHEQK-ALRJYLEOSA-N Proscillaridin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C=C2CC[C@H]3[C@@]4(O)CC[C@H](C5=COC(=O)C=C5)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 MYEJFUXQJGHEQK-ALRJYLEOSA-N 0.000 title abstract 2
- 229960003584 proscillaridin Drugs 0.000 title abstract 2
- MYEJFUXQJGHEQK-UHFFFAOYSA-N proscillaridin A Natural products OC1C(O)C(O)C(C)OC1OC1C=C2CCC3C4(O)CCC(C5=COC(=O)C=C5)C4(C)CCC3C2(C)CC1 MYEJFUXQJGHEQK-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 239000000150 Sympathomimetic Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001975 sympathomimetic effect Effects 0.000 abstract 2
- 229960000278 theophylline Drugs 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000009090 positive inotropic effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229960004767 proxyphylline Drugs 0.000 abstract 1
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 abstract 1
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical class CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB0085102 | 1965-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1173322A true GB1173322A (en) | 1969-12-10 |
Family
ID=6982752
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2723569A Expired GB1173322A (en) | 1965-12-22 | 1966-12-01 | Pharmaceutical Compositions containing Proscillaridin A |
| GB5394166A Expired GB1173321A (en) | 1965-12-22 | 1966-12-01 | Pharmaceutical Compositions containing Proscillaridin A |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5394166A Expired GB1173321A (en) | 1965-12-22 | 1966-12-01 | Pharmaceutical Compositions containing Proscillaridin A |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE691525A (en:Method) |
| CH (1) | CH504869A (en:Method) |
| DE (1) | DE1467801A1 (en:Method) |
| ES (1) | ES334627A1 (en:Method) |
| FR (1) | FR7014M (en:Method) |
| GB (2) | GB1173322A (en:Method) |
| NL (2) | NL6617599A (en:Method) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023239747A3 (en) * | 2022-06-06 | 2024-01-18 | University Of Utah Research Foundation | Methods of modulating atxn2 expression |
-
1965
- 1965-12-22 DE DE19651467801 patent/DE1467801A1/de active Pending
-
1966
- 1966-12-01 GB GB2723569A patent/GB1173322A/en not_active Expired
- 1966-12-01 GB GB5394166A patent/GB1173321A/en not_active Expired
- 1966-12-14 NL NL6617599A patent/NL6617599A/xx unknown
- 1966-12-17 ES ES334627A patent/ES334627A1/es not_active Expired
- 1966-12-20 BE BE691525D patent/BE691525A/xx unknown
- 1966-12-20 FR FR88166A patent/FR7014M/fr not_active Expired
- 1966-12-21 CH CH1824466A patent/CH504869A/de not_active IP Right Cessation
-
1971
- 1971-02-09 NL NL7101670A patent/NL7101670A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023239747A3 (en) * | 2022-06-06 | 2024-01-18 | University Of Utah Research Foundation | Methods of modulating atxn2 expression |
Also Published As
| Publication number | Publication date |
|---|---|
| FR7014M (en:Method) | 1969-06-09 |
| NL7101670A (en:Method) | 1971-05-25 |
| NL6617599A (en:Method) | 1967-06-23 |
| ES334627A1 (es) | 1968-03-16 |
| CH504869A (de) | 1971-03-31 |
| DE1467801A1 (de) | 1968-12-12 |
| GB1173321A (en) | 1969-12-10 |
| BE691525A (en:Method) | 1967-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| USRE32393F1 (en) | Composition for enhancing the administration of pharmacologically active agents | |
| ES483894A1 (es) | Un procedimiento para la preparacion de una sal de adicion -de acido de un derivado de androstano. | |
| GB903866A (en) | Therapeutic preparations containing 7-substituted theophylline derivatives | |
| IE32612L (en) | Pharmaceutical composition | |
| NL174252C (nl) | Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van voor toepassing daarbij geschikte 4h-s-triazolo(4,3-a)(1,4)-benzodiazepinederivaten met sedatieve en anticonvulsieve werking. | |
| GB1173322A (en) | Pharmaceutical Compositions containing Proscillaridin A | |
| GB1115893A (en) | Pharmaceutical anti-allergic compositions | |
| ZA71951B (en) | Dosage units for the administration of medicaments and the like | |
| GB1210593A (en) | Pharmaceutical compositions containing coumarin derivatives | |
| GB1300486A (en) | Compositions for the treatment of respiratory ailments in man | |
| ES373657A1 (es) | Un procedimiento para la preparacion de derivados simetri- cos de di-hidrotriazina n-sustituidos. | |
| IE32384L (en) | Antibiotic veterinary composition | |
| GB1129134A (en) | Improvements in compositions containing nicotinates | |
| GB911179A (en) | Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone | |
| GB1154318A (en) | Improvements in Vitamin B12 Compositions | |
| WO1990006116A3 (de) | Mittel zur behandlung von chronisch entzündlichen darmerkrankungen | |
| GB1289039A (en:Method) | ||
| GB1167688A (en) | Dealkylation of Cyclic N-alkyl Derivatives | |
| GB1318533A (en) | 3-2-cyanophenoxy-2-hydroxy-n-ethyl-propylamine | |
| FR1601724A (en) | Drug aluminium chelates | |
| GB1111433A (en) | A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions | |
| GB1269616A (en) | Improvements in pharmaceutical compositions | |
| GB1092737A (en) | 2-methoxy-4-[n-glutarylsulfanilamido]quinazoline and process for preparing the same | |
| GB1287433A (en) | Pharmaceutical compositions | |
| GB1076458A (en) | Analeptic compositions comprising 1,4-endomethylene-í¸-cyclohexene-transdicarboxylic acid bis-diethylamide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |